Figure 3.
(A) DOX loading efficiency of PEG-TaS2 NSs. The insert shows the picture of aqueous dispersions of PEG-TaS2 NSs with increased DOX loading efficiency. (B) DOX release from PEG-TaS2 NSs under different conditions. (C) Cell viability of PC3 cells after treatment with various groups. (D) Western blot analysis of phospho-p38 (p-p38) and p38 expression in PC3 cells after treatments with various groups.